Xr Securities LLC Sellas Life Sciences Group, Inc. Transaction History
Xr Securities LLC
- $5.35 Billion
- Q4 2024
A detailed history of Xr Securities LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Xr Securities LLC holds 13,100 shares of SLS stock, worth $15,589. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,100Holding current value
$15,589% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SLS
# of Institutions
37Shares Held
6.49MCall Options Held
1.8MPut Options Held
49.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.73 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.19MShares$1.42 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA734KShares$872,9190.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il485KShares$577,5270.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$512,1370.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $24.5M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...